QNRX vs. ACXP
QNRX (Quoin Pharmaceuticals Ltd DRC) and ACXP (Acurx Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, QNRX returned -73.86%/yr vs -69.14%/yr for ACXP. At a 0.11 correlation, their price movements are largely independent.
Performance
QNRX vs. ACXP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QNRX achieves a -69.44% return, which is significantly lower than ACXP's -39.36% return.
QNRX
- 1D
- -5.16%
- 1M
- -7.55%
- YTD
- -69.44%
- 6M
- -67.93%
- 1Y
- -49.31%
- 3Y*
- -73.86%
- 5Y*
- -85.89%
- 10Y*
- —
ACXP
- 1D
- -1.95%
- 1M
- -23.35%
- YTD
- -39.36%
- 6M
- -56.23%
- 1Y
- -86.27%
- 3Y*
- -69.14%
- 5Y*
- —
- 10Y*
- —
QNRX vs. ACXP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
QNRX Quoin Pharmaceuticals Ltd DRC | -69.44% | -36.64% | -86.73% | -71.21% | -93.76% | -87.47% |
ACXP Acurx Pharmaceuticals, Inc. | -39.36% | -84.71% | -78.75% | -3.77% | -7.90% | -27.37% |
Correlation
The correlation between QNRX and ACXP is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Jun 25, 2021 | 0.11 |
Fundamentals
QNRX:
$12.48M
ACXP:
$4.10M
QNRX:
-$13.39
ACXP:
-$959.29
QNRX:
1.42
ACXP:
0.00
QNRX:
$0.00
ACXP:
$0.00
QNRX:
-$24.93K
ACXP:
$0.00
QNRX:
-$17.28M
ACXP:
-$5.88M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QNRX vs. ACXP — Risk / Return Rank
QNRX
ACXP
QNRX vs. ACXP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quoin Pharmaceuticals Ltd DRC (QNRX) and Acurx Pharmaceuticals, Inc. (ACXP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QNRX | ACXP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.20 | ||
| Sortino ratioReturn per unit of downside risk | +1.55 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 0.91 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | -0.61 | -0.97 | +0.36 |
| Martin ratioReturn relative to average drawdown | -0.98 | -1.25 | +0.27 |
Loading charts...
Drawdowns
QNRX vs. ACXP - Drawdown Comparison
The maximum QNRX drawdown since its inception was -100.00%, roughly equal to the maximum ACXP drawdown of -99.14%. Use the drawdown chart below to compare losses from any high point for QNRX and ACXP.
Loading charts...
Drawdown Indicators
| QNRX | ACXP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -99.14% | -0.86% |
Max Drawdown (1Y)Largest decline over 1 year | -81.17% | -89.26% | +8.09% |
Max Drawdown (3Y)Largest decline over 3 years | -98.68% | -98.83% | +0.15% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -99.04% | -0.96% |
Average DrawdownAverage peak-to-trough decline | -81.53% | -69.51% | -12.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 50.56% | 69.15% | -18.59% |
Volatility
QNRX vs. ACXP - Volatility Comparison
Quoin Pharmaceuticals Ltd DRC (QNRX) has a higher volatility of 23.57% compared to Acurx Pharmaceuticals, Inc. (ACXP) at 12.17%. This indicates that QNRX's price experiences larger fluctuations and is considered to be riskier than ACXP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QNRX | ACXP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.57% | 12.17% | +11.40% |
Volatility (6M)Calculated over the trailing 6-month period | 60.92% | 119.74% | -58.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 190.41% | 188.57% | +1.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 213.65% | 140.92% | +72.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 172.31% | 140.92% | +31.39% |
Dividends
QNRX vs. ACXP - Dividend Comparison
Neither QNRX nor ACXP has paid dividends to shareholders.
Financials
QNRX vs. ACXP - Financials Comparison
This section allows you to compare key financial metrics between Quoin Pharmaceuticals Ltd DRC and Acurx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
QNRX and ACXP have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QNRX has higher volatility (23.57%) compared to ACXP (12.17%). In terms of maximum drawdown, QNRX dropped -100.00% vs ACXP's -99.14%.
QNRX currently has the higher Sharpe Ratio (-0.26 vs -0.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QNRX and ACXP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer